Device Negative Pressure Systems & Dressings

V.A.C. Veraflo

Payments companies reported to CMS as associated with V.A.C. Veraflo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3.2Massociated payments (2023-2025)
6,083clinicians with associated payments
2companies reporting

By year

2023 $1.2M
2024 $1.1M
2025 $946K

Payments reported as associated with V.A.C. Veraflo, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Plastic Surgery $777K
Foot & Ankle Surgery $456K
Surgery $343K
Orthopaedic Surgery $316K
Surgical Critical Care $289K
Plastic and Reconstructive Surgery $208K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with V.A.C. Veraflo

These are the largest totals companies reported as associated with V.A.C. Veraflo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Dana Figura Santa Monica, CA Foot & Ankle Surgery $265,000.00
Devinder Singh Miami, FL Plastic Surgery $189,057.31
Michael Desvigne Glendale, AZ Plastic and Reconstructive Surgery $174,802.47
Neilendu Kundu Cleveland, OH Surgery $163,988.13
Casey Thomas Las Vegas, NV Surgical Critical Care $129,378.34
Anthony Dardano Boca Raton, FL Plastic Surgery $124,512.41
Abhishek Chatterjee Lebanon, NH Surgery $112,888.78
Luther Holton Wilmington, NC Plastic Surgery $101,200.73
Ravi Karia San Antonio, TX Orthopaedic Surgery $98,857.16
Paul Kim Dallas, TX Foot & Ankle Surgery $98,842.79

Prescribed V.A.C. Veraflo?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.